Editorial
doi: 10.1053/j.ajkd.2022.02.012.
Epub 2022 Apr 21.
Managing Hyperkalemia to Enable Guideline-Recommended Dosing of Renin-Angiotensin-Aldosterone System Inhibitors
Affiliations
- PMID: 35461743
- DOI: 10.1053/j.ajkd.2022.02.012
Item in Clipboard
Editorial
Managing Hyperkalemia to Enable Guideline-Recommended Dosing of Renin-Angiotensin-Aldosterone System Inhibitors
Am J Kidney Dis.
2022 Aug.
Erratum in
-
Erratum Regarding "Managing Hyperkalemia to Enable Guideline-Recommended Dosing of Renin-Angiotensin-Aldosterone System Inhibitors" (Am J Kidney Dis. 2022;80[2]:159-160).Am J Kidney Dis. 2022 Nov;80(5):690. doi: 10.1053/j.ajkd.2022.09.001. Am J Kidney Dis. 2022. PMID: 36273832 No abstract available.
No abstract available
Comment on
-
Hyperkalemia-Related Discontinuation of Renin-Angiotensin-Aldosterone System Inhibitors and Clinical Outcomes in CKD: A Population-Based Cohort Study.Am J Kidney Dis. 2022 Aug;80(2):164-173.e1. doi: 10.1053/j.ajkd.2022.01.002. Epub 2022 Jan 25. Am J Kidney Dis. 2022. PMID: 35085685
Similar articles
-
New Therapeutic Approaches for the Treatment of Hyperkalemia in Patients Treated with Renin-Angiotensin-Aldosterone System Inhibitors.Cardiovasc Drugs Ther. 2018 Feb;32(1):99-119. doi: 10.1007/s10557-017-6767-5. Cardiovasc Drugs Ther. 2018. PMID: 29372448 Review.
-
New potassium binders reduce the risk of hyperkalaemia in patients treated with renin-angiotensin-aldosterone system inhibitors.Eur Heart J Cardiovasc Pharmacother. 2018 Oct 1;4(4):193-194. doi: 10.1093/ehjcvp/pvy019. Eur Heart J Cardiovasc Pharmacother. 2018. PMID: 29982385 No abstract available.
-
Treatment with patiromer decreases aldosterone in patients with chronic kidney disease and hyperkalemia on renin-angiotensin system inhibitors.Kidney Int. 2016 Sep;90(3):696-704. doi: 10.1016/j.kint.2016.04.019. Epub 2016 Jun 24. Kidney Int. 2016. PMID: 27350174 Clinical Trial.
-
Potassium homeostasis and renin-angiotensin-aldosterone system inhibitors.Clin J Am Soc Nephrol. 2010 Mar;5(3):531-48. doi: 10.2215/CJN.07821109. Epub 2010 Feb 11. Clin J Am Soc Nephrol. 2010. PMID: 20150448 Review.
-
Potassium-Binding Agents to Facilitate Renin-Angiotensin-Aldosterone System Inhibitor Therapy.Ann Pharmacother. 2016 Jun;50(6):502-10. doi: 10.1177/1060028016640794. Epub 2016 Mar 23. Ann Pharmacother. 2016. PMID: 27009290 Review.
Cited by
-
Hyperkalemia in pediatric chronic kidney disease.Pediatr Nephrol. 2023 Sep;38(9):3083-3090. doi: 10.1007/s00467-023-05912-2. Epub 2023 Mar 20. Pediatr Nephrol. 2023. PMID: 36939915 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
